BPA Call HT942523A0001-HT009025FG0910029
- Not listed
- The Defense Health Agency awarded Cerilliant Corporation a $37,499.78 firm fixed-price Blanket Purchase Agreement (BPA) call on August 8, 2025, for drug standards to be used in screening and confirmation testing of suspected drug use in service member urine, blood, and tissue samples, both for living personnel and post-mortem analysis. The contract represents a task order against Cerilliant's existing BPA with the Defense Health Agency and carries an ultimate completion date of September 30,...
- The Defense Health Agency awarded a Blanket Purchase Agreement (BPA) call valued at approximately $42.5K to Cerilliant Corporation for drug standards to be used in screening and confirmation testing of suspected drug use in service member and post-mortem urine, blood, and tissue samples. The contract, awarded on June 18, 2025, with a completion date of September 30, 2025, is structured as a firm fixed-price arrangement with no set-aside designation. Performance will be conducted at...
- This federal contract award is a Blanket Purchase Agreement (BPA) call issued by the Defense Health Agency (DHA) to Cerilliant Corporation, a global leader in certified reference materials and laboratory supplies. The contract, valued at $8,279.36, is for the provision of drug reference standards to support the DHA's drug screening and testing programs for service members. Cerilliant Corporation is a foreign-owned, for-profit manufacturer based in Texas, with over 30 years of experience as a...
- Cerilliant Corporation was awarded a $19,723.40 firm fixed price blanket purchase agreement call from the Defense Health Agency to provide drug supplies. As a global leader in certified reference standards for over 30 years, Cerilliant will deliver chemical reference materials from its Round Rock, Texas headquarters to support agency testing and healthcare programs at the place of performance in Fort Meade, Maryland. Cerilliant currently holds several indefinite delivery/indefinite quantity...
- This is a federal contract award to Cerilliant Corporation, a foreign-owned, for-profit manufacturer of chemical and biological reference materials based in Round Rock, Texas. The contract, awarded by the Defense Health Agency (DHA), is for the provision of medical supplies. The contract is a Blanket Purchase Agreement (BPA) call, with a firm fixed-price pricing type and a ceiling value of $32,348.38. The contract is set to expire on September 30, 2023. Cerilliant Corporation has a history of...
- This federal contract award to Cerilliant Corporation is a Blanket Purchase Agreement (BPA) call with the Defense Health Agency (DHA), valued at $15,522.70. The contract is for the provision of drug reference standards and calibration materials to support drug testing and screening of service member specimens, including post-mortem urine, blood, and tissue samples. The contract has a completion date of August 15, 2024 and is a firm fixed price arrangement. Cerilliant Corporation is a global...
- This is a BPA (Blanket Purchase Agreement) call awarded by the Defense Health Agency (DHA) to Cerilliant Corporation, a global leader in certified reference materials. The contract, valued at $11,104.95, is for the supply of FTDTL (Forensic Toxicology Drug Testing Laboratory) Cerilliant supplies for the Fort Meade location. This BPA call is part of a larger $250,000 DHA BPA that Cerilliant holds to provide drug reference standards through September 2028. Cerilliant, a foreign-owned, for-profit...
- Cerilliant Corporation was awarded a firm fixed price call against the Defense Health Agency's blanket purchase agreement for the provision of $5,881.55 worth of reagent and laboratory supplies. As a global leader in reference standards and with over 30 years of experience supplying partners, Cerilliant will deliver certified chemical and biological reference materials to support testing and healthcare programs at the Defense Health Agency located in Fort Meade, Maryland. Cerilliant primarily...
- Cerilliant Corporation was awarded a firm fixed price call against the Blanket Purchase Agreement with the Defense Health Agency with a potential value of $19,158.95. The contract is for the provision of reference standards, reagents, calibrators and other laboratory materials to support testing and healthcare programs at Fort Meade, Maryland. No set aside designation was applied. Cerilliant is a global leader in supplying chemical and biological reference standards to federal agencies. They...
- This federal contract award is a BPA (Blanket Purchase Agreement) call for drug reference standards and related supplies from Cerilliant Corporation, a global leader in certified reference materials. The contract has a total ceiling value of $9,906.25 and is awarded to Cerilliant by the Defense Health Agency (DHA), a defense agency within the Department of Defense. The contract delivers drug reference standards, calibrators, reagents, and laboratory materials to support research, testing,...
- HT942523A0001Blanket Purchase Agreement
- HT942523A0001-HT009025FG0910029BPA Call
The Defense Health Agency awarded a $21,685.45 firm fixed price Blank Purchase Agreement (BPA) call to Cerilliant Corporation for drug standards to be used in screening and analysis testing for suspected drug use in service member blood, urine, and/or tissue testing. This contract, which was not issued under any set-aside designation, leverages Cerilliant's established Indefinite Delivery Vehicle with the Defense Health Agency—a $250,000 BPA for drug reference standards and laboratory supplies extending through September 2028. The work will be performed at Cerilliant's facility in Round Rock, Texas, with an ultimate completion date of September 30, 2025. Cerilliant Corporation, a global leader in certified reference materials and laboratory supplies headquartered in Round Rock, Texas, specializes in providing high-quality chemical and biological reference standards to defense and health-related organizations. As a foreign-owned manufacturer, the company has established a strong track record with federal agencies including the Defense Health Agency, Centers for Disease Control and Prevention, National Institutes of Health, and the Department of the Army Medical Command. This contract supports the Defense Health Agency's mission to provide comprehensive health services to service members by supplying critical drug reference materials necessary for toxicology screening and confirmation testing across the military healthcare system.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $21.7k | 9/3/25 |